Patients begin with a virtual video visit with a licensed physician associate or nurse practitioner, who reviews their health history and weight-management goals before determining whether a GLP-1 therapy is the right fit
doi: 10.1177/0890117117696244
This peptide has been extensively studied in the context of glioblastoma and neuroblastoma where those proteins are all involved in cell migration and invasion, as recently reviewed by Boltman and colleagues (Veiseh et al., 2007
A double-blind, randomized, controlled trial in 1999 demonstrated that a third of patients who received the drug lost greater than five percent of their body weight and saw a significant drop in their serum lipid levels
Biohacker Protocol (experimental) Dose: 0.5 mg Tesamorelin + 100 mcg Ipamorelin Duration: Continuous (12+ weeks) Frequency: 5 days on, 2 days off Cycle Interval: No fixed washout
Microglia-mediated inflammation and neural stem cell differentiation in Alzheimers disease: possible therapeutic role of K(V)1.3 channel blockade